Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation
- PMID: 8177726
Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation
Abstract
There has been substantial progress in preventing and treating CMV infection. Prophylaxis with CMV screened blood products, IVIG and antiviral drugs (high dose acyclovir and/or Ganciclovir) considerably reduce the incidence of CMV disease and nearly eliminate CMV pneumonia after allogeneic BMT.